Literature DB >> 23937370

Developmental and behavioral pediatricians' attitudes toward screening for fragile X.

Kruti Acharya1, Abigail Schindler.   

Abstract

Developmental and behavioral pediatricians (DBP) diagnose and care for children with fragile X syndrome. Their attitudes toward FMR1 newborn screening (NBS) and FMR1 carrier testing in childhood could highlight potential pitfalls with FMR1 NBS. We conducted a cross-sectional survey with an adjusted response rate of 61%. Among DBP, 74% supported universal FMR1 NBS, preferring to identify both full mutations and premutations. DBP also support FMR1 testing of asymptomatic siblings. Although DBP support testing for premutations at various points in the lifespan, DBP are not familiar with the array of fragile X-associated disorders (FXAD). Targeted educational interventions are needed to ensure that all health care providers have the knowledge and competence to consent and to counsel families on FXAD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23937370      PMCID: PMC3744113          DOI: 10.1352/1944-7558-188.4.284

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  35 in total

1.  Communication of genetic risk information to daughters in families with fragile X syndrome: the parent's perspective.

Authors:  Allyn McConkie-Rosell; Jacqueline Del Giorno; Elizabeth Melvin Heise
Journal:  J Genet Couns       Date:  2010-09-28       Impact factor: 2.537

2.  Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.

Authors:  Marsha Mailick Seltzer; Mei Wang Baker; Jinkuk Hong; Matthew Maenner; Jan Greenberg; Daniel Mandel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-22       Impact factor: 3.568

3.  Newborn screening for fragile x syndrome: do we care what parents think?

Authors:  Jeffrey R Botkin
Journal:  Pediatrics       Date:  2011-05-29       Impact factor: 7.124

4.  Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project.

Authors:  Debra Skinner; Summer Choudhury; John Sideris; Sonia Guarda; Allen Buansi; Myra Roche; Cynthia Powell; Donald B Bailey
Journal:  Pediatrics       Date:  2011-05-29       Impact factor: 7.124

5.  Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society.

Authors:  P A Filipek; P J Accardo; S Ashwal; G T Baranek; E H Cook; G Dawson; B Gordon; J S Gravel; C P Johnson; R J Kallen; S E Levy; N J Minshew; S Ozonoff; B M Prizant; I Rapin; S J Rogers; W L Stone; S W Teplin; R F Tuchman; F R Volkmar
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

6.  Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

Authors:  F Tassone; C M Greco; M R Hunsaker; A L Seritan; R F Berman; L W Gane; S Jacquemont; K Basuta; L-W Jin; P J Hagerman; R J Hagerman
Journal:  Genes Brain Behav       Date:  2012-04-06       Impact factor: 3.449

7.  American Academy of Pediatrics: The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children.

Authors: 
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

8.  Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome.

Authors:  M Lessard; A Chouiali; R Drouin; G Sébire; F Corbin
Journal:  Clin Genet       Date:  2011-11-29       Impact factor: 4.438

9.  Attitudes of pediatric residents toward ethical issues associated with genetic testing in children.

Authors:  Ami Rosen; Sylvan Wallenstein; Margaret M McGovern
Journal:  Pediatrics       Date:  2002-08       Impact factor: 7.124

10.  Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms.

Authors:  Jessica Ezzell Hunter; Mary Leslie; Gloria Novak; Debra Hamilton; Lisa Shubeck; Krista Charen; Ann Abramowitz; Michael P Epstein; Adriana Lori; Elisabeth Binder; Joseph F Cubells; Stephanie L Sherman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-09       Impact factor: 3.568

View more
  6 in total

1.  Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers.

Authors:  Emily C Lisi; Shawn E McCandless
Journal:  J Genet Couns       Date:  2015-08-29       Impact factor: 2.537

2.  A theory-informed systematic review of clinicians' genetic testing practices.

Authors:  Jean L Paul; Hanna Leslie; Alison H Trainer; Clara Gaff
Journal:  Eur J Hum Genet       Date:  2018-06-11       Impact factor: 4.246

3.  Severe Combined Immunodeficiency: Knowledge and Information Needs Among Healthcare Providers.

Authors:  Oksana Kutsa; Angela Gwaltney; Alissa Creamer; Melissa Raspa
Journal:  Front Pediatr       Date:  2022-02-21       Impact factor: 3.418

Review 4.  Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders.

Authors:  Indhu-Shree Rajan-Babu; Samuel S Chong
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

5.  Fragile X-Associated Disorders in Serbia: Baseline Quantitative and Qualitative Survey of Knowledge, Attitudes and Practices Among Medical Professionals.

Authors:  Dejan B Budimirovic; Smiljana Cvjetkovic; Zoran Bukumiric; Phan Q Duy; Dragana Protic
Journal:  Front Neurosci       Date:  2018-09-21       Impact factor: 4.677

6.  Attitudes toward population screening among people living with fragile X syndrome in the UK: 'I wouldn't wish him away, I'd just wish his fragile X syndrome away'.

Authors:  Felicity K Boardman
Journal:  J Genet Couns       Date:  2020-11-12       Impact factor: 2.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.